| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $73.7M | +16.7% |
| Cost of Revenue | $30.8M | -4.1% |
| R&D Expense | $10.9M | +299.5% |
| SG&A Expense | $59.5M | +49.3% |
| Operating Income | -$27.5M | +21.1% |
| Interest Expense | $2.0M | -71.3% |
| Pre-tax Income | -$29.6M | +30.2% |
| Income Tax | $63K | -96.1% |
| Net Income | -$29.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.0M | -34.8% |
| Accounts Receivable | $28.2M | +22.0% |
| Inventory | $14.2M | +43.6% |
| Current Assets | $77.7M | -8.1% |
| Total Assets | $105.2M | +8.1% |
| Current Liabilities | $66.8M | +29.5% |
| Long-term Debt | $27.8M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.5M | -520.5% |
| Investing Cash Flow | -$20.0M | -100.0% |
| Financing Cash Flow | $16.5M | -69.0% |
| +32.7% |
| EPS (Basic) | -$1.69 | +60.9% |
| EPS (Diluted) | -$1.69 | +60.9% |
| Total Liabilities |
| $88.2M |
| +59.6% |
| Stockholders' Equity | $17.0M | -59.6% |